Debate on the Sechat Portal podcast compares Rivotril and medical cannabis, highlighting effectiveness, safety, side effects, and differences between acute use and long-term treatment

Experiment aims to expose plants to microgravity for nine months after capsule recovery failure in 2025

Despite agricultural advantages, the country still struggles to advance in the production of hemp concrete used in sustainable construction

The debate brought together experts in law, science, and ethics to discuss evidence, risks, and regulatory models for the therapeutic use of these substances

Process could determine whether the genetics will be classified as a genetically modified organism or treated as a conventional plant in Brazil

Scientific survey indicates that cannabidiol may interfere with mechanisms related to the progression and spread of tumors in different types of cancer

Proposal creates a legal framework for production, importation, and self-cultivation; the report included strict security requirements for the medicinal use of cannabis

Doctor Caliandra turned the search for relieving her father's suffering into a professional mission, finding in cannabis a path of care, science, and hope

Survey conducted with adults in the United States shows majority in favor of legalizing recreational cannabis use and broad recognition of its medicinal use

Court analyzes whether the substance is a medicine or a health product, which directly impacts the funding and access to cannabidiol by the SUS

Research published in the Journal of Cannabis Research combines genetic and chemical analysis to enhance quality control in the pharmaceutical industry

Amid the celebration of Brazilian cinema with "The Secret Agent," we gather national productions that help understand the trajectory of cannabis in the country

Researchers propose THC units to measure cannabis consumption and identify levels associated with a higher risk of cannabis use disorder

Canopy Growth announces financial restructuring and a new loan of US$ 150 million to ensure liquidity and support acquisitions

Sports doctor Jimmy Fardin and dentist Rafaela da Rosa join Deusa Cast to discuss therapeutic applications of cannabis in clinical practice

See which states in the United States may advance in cannabis legalization in 2026, with legislative initiatives and possible popular votes under discussion

Cannabis prices in Oregon (USA) have reached historically low levels, while official data indicates that consumer demand remains stable in the state

Cannabidiol-based medication indicated for rare epilepsies, while Infarmed has been evaluating its inclusion in the public health system for almost four years

Legal action in the United States involves former executives and companies responsible for licensing and managing celebrity-associated cannabis brands

Agreement between regulatory agency and veterinary institute evaluates the use of cannabidiol as an alternative to antibiotics in poultry farming

CTNBio's analysis focuses on the "Badger G" variety, which prioritizes industrial use and high levels of cannabigerol (CBG)

Companies report delays in shipments clearance, while official data from Anvisa indicate reduced average deadlines and high approval rates

Neurosurgeon explains on Deusa Cast podcast how cannabis acts on pain, mood, and multiple symptoms, functioning as a multifunctional therapeutic tool

Associations question the exclusivity of dispensing in hospitals provided for in the new Royal Decree; deadline for defining clinical uses by the regulatory agency expired in early January

Unanimous decision from the 3rd Public Law Chamber benefits a woman, the rapporteur cites STJ criteria

Driven by sustainable demands, the hempcrete market projects an annual growth rate of 3.86% over the next decade, despite regulatory challenges

Driven by sustainable demands, the hempcrete market projects an annual growth rate of 3.86% over the next decade, despite regulatory challenges

Partnership with TWA Brands foresees early purchase of products registered with Anvisa and marks the entry of the European company into Brazil

Ana Gabriela Batista demands, during industry congress, guidelines that facilitate treatments and ensure legal security

While the global index declines, the ETF MSOS accumulates significant gains in 2025, driven by expectations of changes in Section 280E